{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:13:10Z","timestamp":1791411190508,"version":"4.3.3"},"reference-count":209,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1006\/clin.1996.4296","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"103-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["New Insights into the Pathogenesis and Treatment of Rheumatoid Arthritis"],"prefix":"10.1006","volume":"83","author":[{"given":"Majed","family":"Odeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1996.4296_II964296C1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","article-title":"Rheumatoid arthritis: Pathophysiology and implications for therapy","volume":"322","author":"Harris","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0098-2997(91)90016-F","article-title":"Molecular insights into rheumatoid arthritis","volume":"12","author":"Scott","year":"1991","journal-title":"Mol. Aspects Med."},{"key":"10.1006\/clin.1996.4296_II964296C3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0049-0172(95)80031-X","article-title":"Mortality in rheumatoid arthritis","volume":"25","author":"Myllykangas-Luosujarvi","year":"1995","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C4","first-page":"2","article-title":"The paradox of effective therapies but poor long term outcome in rheumatoid arthritis.Semin","volume":"21","author":"Pincus","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198310273091704","article-title":"Does drug therapy slow radiographic deterioration in rheumatoid arthritis?","volume":"309","author":"Iannuzzi","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","article-title":"Long-term outcome of treating rheumatoid arthritis: Results after 20 years","volume":"1","author":"Scot","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C7","first-page":"195","article-title":"The role of cytokines in the regulation of local bone resorption","volume":"11","author":"Lorenzo","year":"1991","journal-title":"Crit. Rev. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1096\/fasebj.2.2.3277884","article-title":"Biology of interleukin-1","volume":"2","author":"Dinarello","year":"1988","journal-title":"FASEB J."},{"key":"10.1006\/clin.1996.4296_II964296C9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/endo-121-3-1164","article-title":"Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin-1","volume":"121","author":"Lorenzo","year":"1987","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/endo-86-6-1436","article-title":"Prostaglandins: Stimulation of bone resorption in tissue culture","volume":"86","author":"Klein","year":"1970","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-4165(88)90008-6","article-title":"Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator","volume":"967","author":"Campbell","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/clin.1996.4296_II964296C13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780380202","article-title":"Inhibition of the production and effects of interleukin-1 and tumor necrosis factor \u03b1 in rheumatoid arthritis","volume":"38","author":"Arend","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","article-title":"Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis","volume":"2","author":"Eastgate","year":"1988","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/ard.51.6.731","article-title":"Determination of cytokines in synovial fluids: Correlation with diagnosis and histomorphological characteristics of synovial tissue","volume":"51","author":"Kahle","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.1780330412","article-title":"Effects of tumor necrosis factor \u03b1 and b on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes","volume":"33","author":"Campbell","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C17","first-page":"1204","article-title":"Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint","volume":"82","author":"Pettipher","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-291X(88)90703-6","article-title":"Inhibition of cartilage proteoglycan synthesis by interleukin-1","volume":"154","author":"Benton","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj2250493","article-title":"Chondrocyte mediated depletion of articular cartilage in vitro","volume":"225","author":"Tyler","year":"1985","journal-title":"Biochem. J."},{"key":"10.1006\/clin.1996.4296_II964296C20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(90)90641-W","article-title":"Similar regulation of chondrocyte functions by cellular stimulants of unknown mechanism: Retinoids, cytokines, and bacterial lipopolysaccharide","volume":"39","author":"Benton","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/clin.1996.4296_II964296C21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/bj2270869","article-title":"Articular cartilage cultured with catabolin (pig interleukin-1) synthesises a decreased number of normal proteoglycan molecules","volume":"227","author":"Tyler","year":"1985","journal-title":"Biochem. J."},{"key":"10.1006\/clin.1996.4296_II964296C22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0174-173X(88)80013-X","article-title":"Synthesis of type II collagen is decreased in cartilage cultured with interleukin-1 while the rate of intracellular degradation remains unchanged","volume":"8","author":"Tyler","year":"1988","journal-title":"Coll. Relat. Res."},{"key":"10.1006\/clin.1996.4296_II964296C23","first-page":"845","article-title":"Hypothesis: In vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus","volume":"10","author":"Hamilton","year":"1983","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/182948a0","article-title":"Action of plasmin on cartilage","volume":"182","author":"Lack","year":"1958","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C25","first-page":"123","article-title":"Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis","volume":"11","author":"Mochan","year":"1984","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1083\/jcb.106.2.311","article-title":"Modulation of fibroblast functions by interleukin-1: Increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin-1 \u03b1 and b","volume":"106","author":"Postlethwaite","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1006\/clin.1996.4296_II964296C27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.2783498","article-title":"interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA","volume":"243","author":"Raines","year":"1989","journal-title":"Science"},{"key":"10.1006\/clin.1996.4296_II964296C28","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood"},{"key":"10.1006\/clin.1996.4296_II964296C29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF01986688","article-title":"The possible role of neutrophil proteinases in damage to articular cartilage","volume":"43","author":"Barrett","year":"1994","journal-title":"Agents Actions"},{"key":"10.1006\/clin.1996.4296_II964296C30","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.83.22.8749","article-title":"Interleukin-1 leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint","volume":"83","author":"Pettipher","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0090-1229(90)90126-B","article-title":"Arthritis induced by interleukin-1 is dependent on the site and frequency of intra-articular injection","volume":"55","author":"Chandrasekhar","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1996.4296_II964296C32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI115453","article-title":"Interleukin-1 receptor antagonist: A new member of the interleukin-1 family","volume":"88","author":"Arend","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1996.4296_II964296C34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780370507","article-title":"Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis","volume":"37","author":"Firestein","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/343341a0","article-title":"Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist","volume":"343","author":"Eisenberg","year":"1990","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.173.4.931","article-title":"Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody","volume":"173","author":"McIntyre","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C37","first-page":"S45","article-title":"Subcutaneous IL-1 receptor antagonist in patients with rheumatoid arthritis (abstract)","volume":"34","author":"Lebsack","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose oral pulse methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/pgmj.69.816.775","article-title":"Methotrexate in rheumatoid arthritis: Can current knowledge and experience justify its use as a first-line disease-modifying agent?","volume":"69","author":"Tariq","year":"1993","journal-title":"Postgrad. Med. J."},{"key":"10.1006\/clin.1996.4296_II964296C40","first-page":"1148","article-title":"The effect of anti rheumatic drugs on interleukin-1 activity and IL-1 and IL-1 inhibitor production by human monocytes","volume":"17","author":"Chang","year":"1990","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C41","first-page":"1678","article-title":"The effects of methotrexate on interleukin-1 in patients with rheumatoid arthritis","volume":"19","author":"Chang","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/ard.51.8.946","article-title":"Circulating cytokine levels in patients with rheumatoid arthritis: Results of a double blind trial with sulphasalazine","volume":"51","author":"Danis","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.3754653","article-title":"Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance","volume":"232","author":"Beutler","year":"1986","journal-title":"Science"},{"key":"10.1006\/clin.1996.4296_II964296C44","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1073\/pnas.85.4.1204","article-title":"Glucocorticoids selectively inhibit the transcription of the interleukin-1 beta gene and decrease the stability of interleukin-1 beta mRNA","volume":"85","author":"Lee","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.51.6.753","article-title":"Anemia of chronic disease in rheumatoid arthritis: Effect of the blunted response to erythropoietin and of interleukin-1 production by marrow macrophages","volume":"51","author":"Smith","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C46","first-page":"99","article-title":"Cachectin: A pluripotent hormone released during the host response to invasion","volume":"43","author":"Cerami","year":"1987","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1006\/clin.1996.4296_II964296C47","first-page":"479","article-title":"Cachectin: More than a tumor necrosis factor","volume":"316","author":"Beutler","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C48","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(89)92394-5","article-title":"Cachectin\/tumor necrosis factor","volume":"ii","author":"Tracey","year":"1989","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C49","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.4049\/jimmunol.138.5.1464","article-title":"Synergistic interactions between interleukin-1, tumor necrosis factor, and lymphotoxin in bone resorption","volume":"138","author":"Stashenko","year":"1987","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C51","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1210\/endo-121-5-1596","article-title":"Effects of tumor necrosis factor on bone formation in vitro","volume":"121","author":"Canalis","year":"1987","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C52","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/endo-123-3-1442","article-title":"Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures","volume":"123","author":"Centrella","year":"1988","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C53","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/endo-120-5-2029","article-title":"Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism","volume":"120","author":"Tshjian","year":"1987","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C54","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/endo-124-3-1424","article-title":"Tumors producing human tumor necrosis factor induce hypercalcemia and osetoclastic bone resorption in nude mice","volume":"124","author":"Johnson","year":"1989","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/322547a0","article-title":"Tumour necrosis factor \u03b1 stimulates resorption and inhibits synthesis of proteoglycan in cartilage","volume":"322","author":"Sakalatvala","year":"1986","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C56","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.162.6.2163","article-title":"Cachectin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts","volume":"162","author":"Dayer","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C57","first-page":"55","article-title":"Chondrocyte-mediated breakdown of cartilage","volume":"14","author":"Steinberg","year":"1987","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C58","first-page":"S118","article-title":"Basic fibroblast growth factor (bFGF) in synovial fluid and synovial cells of rheumatoid arthritis","volume":"34","author":"Takahashi","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C59","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.175.4.1135","article-title":"Angiogenesis inhibition suppresses collagen arthritis","volume":"175","author":"Peacock","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C60","first-page":"76","article-title":"Cytokine expression in rheumatoid arthritis","volume":"30","author":"Brennan","year":"1991","journal-title":"Br. J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/eji.1830190130","article-title":"Mechanism of immune complex mediated damage: Induction of interleukin-1 by immune complexes and synergy with interferon-gamma and tumour necrosis factor \u03b1","volume":"19","author":"Chantry","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF01972788","article-title":"Effect of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 on cartilage proteoglycan metabolism in vitro","volume":"27","author":"Pratta","year":"1989","journal-title":"Agents Actions"},{"key":"10.1006\/clin.1996.4296_II964296C63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0006-291X(86)90881-8","article-title":"Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages","volume":"136","author":"Bachwich","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C64","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.163.6.1363","article-title":"Tumor necrosis factor\/cachectin interacts with endothelial cell receptors to induce release of interleukin-1","volume":"163","author":"Nawroth","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(92)90172-L","article-title":"Articular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activity","volume":"140","author":"Tiku","year":"1992","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/rheumatology\/30.4.265","article-title":"Role of TNF-\u03b1 in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage","volume":"30","author":"Wilbrink","year":"1991","journal-title":"Br. J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C67","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/cs0850569","article-title":"Induction of enhanced responsiveness of human articular chondrocytes to extracellular ATP by tumour necrosis factor-\u03b1","volume":"85","author":"Leong","year":"1993","journal-title":"Clin. Sci."},{"key":"10.1006\/clin.1996.4296_II964296C68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.49.9.665","article-title":"Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis","volume":"49","author":"Tetta","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C69","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780310816","article-title":"Detection of tumour necrosis factor \u03b1 but not tumour necrosis factor b in rheumatoid arthritis synovial fluid and serum","volume":"31","author":"Saxne","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0008-8749(89)90154-8","article-title":"Characteristics of tumour necrosis factor production in rheumatoid arthritis","volume":"122","author":"Yocum","year":"1989","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/art.1780360409","article-title":"Levels of circulating tumour necrosis factor \u03b1 and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulphate","volume":"36","author":"Manicourt","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C72","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0896-8411(88)90006-6","article-title":"Synovial localisation of tumour necrosis factor in patients with rheumatoid arthritis","volume":"1","author":"Husby","year":"1988","journal-title":"J. Autoimmun."},{"key":"10.1006\/clin.1996.4296_II964296C73","first-page":"480","article-title":"Cytokine production in the rheumatoid joint: Implications of treatment","volume":"49","author":"Feldmann","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C74","first-page":"253","article-title":"Effects of tumor necrosis factor alpha (TNF-\u03b1) on collagen arthritis","volume":"11","author":"Brahn","year":"1992","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1006\/clin.1996.4296_II964296C75","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C76","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"key":"10.1006\/clin.1996.4296_II964296C77","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.87.19.7380","article-title":"Cloning of human tumor necrosis factor (TNF) receptor cDNA and expressing of recombinant soluble TNF-binding protein","volume":"87","author":"Gray","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C78","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/eji.1830220734","article-title":"Enhanced expression of TNF receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints","volume":"22","author":"Brennan","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C79","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351009","article-title":"Localization of tumor necrosis factor receptors in the synovial tissue and cartilage\u2013pannus junction in patients with rheumatoid arthritis: Implications for local actions of tumor necrosis factor \u03b1","volume":"35","author":"Deleuran","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C80","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351008","article-title":"Increased levels of soluble tumor necrosis factor receptor in the sera and synovial fluid of patients with rheumatic disease","volume":"35","author":"Cope","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C81","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","article-title":"Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor \u03b1, and interleukin-6 levels in rheumatoid arthritis: Longitudinal evaluation during methotrexate and azathioprine therapy","volume":"36","author":"Barrera","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C82","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.1780370207","article-title":"Mechanisms of methotrexate action in rheumatoid arthritis","volume":"37","author":"Firestein","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/anr.1780320105","article-title":"Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment","volume":"32","author":"Hale","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C84","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/art.1780361107","article-title":"Up-regulation by tumor necrosis factor \u03b1 of intracellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids","volume":"36","author":"Tessier","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C85","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/art.1780331204","article-title":"Role of cytokines in inflammatory synovitis: The coordinate regulation of intracellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts","volume":"33","author":"Chin","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C86","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/art.1780341007","article-title":"T-lymphocyte adhesion to human synovial fibroblasts: Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a\/CD18","volume":"34","author":"Krzesicki","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C87","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.147.12.4167","article-title":"ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats","volume":"147","author":"Iigo","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C88","first-page":"171","article-title":"Mechanisms of erythroid suppression in the anemia of chronic disease","volume":"13","author":"Roodman","year":"1987","journal-title":"Blood Cells"},{"key":"10.1006\/clin.1996.4296_II964296C89","first-page":"1505","article-title":"Rheumatoid cachexia: Depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor","volume":"19","author":"Roubenoff","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C90","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor \u03b1","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C91","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blinded comparison of chimeric monoclonal antibodies to tumor necrosis factor \u03b1 (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C92","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(94)90632-7","article-title":"Repeated therapy with monoclonal antibody to tumour necrosis factor \u03b1 (cA2) in patients with rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0167-5699(90)90173-7","article-title":"Biological and clinical aspects of interleukin-6","volume":"11","author":"Hirano","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1996.4296_II964296C94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-5699(88)91200-5","article-title":"Multiple actions of interleukin-6 within a cytokine network","volume":"9","author":"Wong","year":"1988","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1996.4296_II964296C95","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","article-title":"IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release","volume":"144","author":"Kurihara","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(90)81404-C","article-title":"Interleukin-1 beta induces synthesis and secretion of interleukin-6 in human chondrocytes","volume":"263","author":"Bender","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1006\/clin.1996.4296_II964296C97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.1780330302","article-title":"Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C98","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","article-title":"Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides","volume":"31","author":"Houssiau","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C99","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/ard.53.8.521","article-title":"Circadian rhythm of serum interleukin-6 in rheumatoid arthritis","volume":"53","author":"Arvidson","year":"1994","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/ard.54.1.33","article-title":"Interleukin-6 in relation to other pro inflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid","volume":"54","author":"VanLeeuwen","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C101","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI113921","article-title":"Synovium as a source of interleukin-6 in vitro: Contribution to local and systemic manifestations of arthritis","volume":"83","author":"Guerne","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C102","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/eji.1830181122","article-title":"Excessive production of interleukin-6\/B cell stimulatory factor-2 in rheumatoid arthritis","volume":"18","author":"Hirano","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C103","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.84.1.228","article-title":"Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production","volume":"84","author":"Hirano","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0167-5699(89)90136-9","article-title":"Inflammatory and immunomodulatory roles of TGF-\u03b2","volume":"10","author":"Wahl","year":"1989","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1996.4296_II964296C105","first-page":"79","article-title":"The cell biology of transforming growth factor b","volume":"1032","author":"Barnard","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/clin.1996.4296_II964296C106","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor b in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C107","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4049\/jimmunol.145.8.2514","article-title":"Antagonistic and agonistic effects of transforming growth factor-\u03b2 and IL-1 in rheumatoid synovium","volume":"145","author":"Wahl","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C108","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1073\/pnas.82.13.4535","article-title":"Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse clavaria","volume":"82","author":"Tashjian","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C109","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jbmr.5650060210","article-title":"Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function","volume":"6","author":"Hattersley","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clin.1996.4296_II964296C110","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.146.8.2633","article-title":"Effects of transforming growth factor-\u03b2 and IL-1\u03b1 on prostaglandin synthesis in serum-deprived osteoblastic cells","volume":"146","author":"Marusic","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C111","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.1780330819","article-title":"Low levels of interleukin-4 and high levels of transforming growth factor b in rheumatoid synovitis","volume":"33","author":"Miossec","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C112","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.4049\/jimmunol.144.11.4189","article-title":"Transforming growth factor-\u03b2 and cellular immune responses in synovial fluids","volume":"144","author":"Lotz","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C113","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.171.1.231","article-title":"Rapid onset of synovial inflammation and hyperplasia induced by transforming growth factor b","volume":"171","author":"Allen","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C114","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.173.5.1121","article-title":"Transforming growth factor b1 (TGF\/b1) induced neutrophil recruitment to synovial tissues: Implications for TGF-\u03b21 driven inflammation and synovial hyperplasia","volume":"173","author":"Fava","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1992.tb06939.x","article-title":"Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor-beta","volume":"89","author":"Cooper","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C116","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM198911233212106","article-title":"Hematopoietic growth factors","volume":"321","author":"Groopamn","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4296_II964296C117","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI113971","article-title":"Cytokines in chronic inflammatory arthritis. II. Granulocyte\u2013macrophage colony-stimulating factor in rheumatoid synovial effusions","volume":"83","author":"Xu","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C118","first-page":"67","article-title":"The detection and initial characterization of colony stimulating factors in synovial fluid","volume":"72","author":"Williamson","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C119","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.141.11.3882","article-title":"Granulocyte macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function","volume":"141","author":"Fischer","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C120","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4049\/jimmunol.143.4.1198","article-title":"Macrophage activation by granulocyte\/macrophage colony stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2","volume":"143","author":"Heidenreich","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C121","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.170.3.865","article-title":"Cytokines in chronic inflammatory arthritis IV. Granulocyte\/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis","volume":"170","author":"Alvaro-Gracia","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI113111","article-title":"Differential expression of Ia antigens by rheumatoid synovial lining cells","volume":"80","author":"Burmester","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C123","first-page":"439","article-title":"Chemotactic activity of human recombinant granulocyte\u2013macrophage colony stimulating factor","volume":"60","author":"Wang","year":"1987","journal-title":"Immunology"},{"key":"10.1006\/clin.1996.4296_II964296C124","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/332647a0","article-title":"GM\u2013CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism","volume":"332","author":"Weisbart","year":"1988","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C125","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.4049\/jimmunol.131.6.2983","article-title":"Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors","volume":"131","author":"Lopex","year":"1983","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C126","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/314361a0","article-title":"Human granulocyte\u2013macrophage colony-stimulating factor is a neutrophil activator","volume":"314","author":"Weisbart","year":"1985","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4296_II964296C127","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/eji.1830211039","article-title":"Expression of granulocyte\u2013macrophage colony stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor-\u03b1","volume":"21","author":"Haworth","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C128","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.4049\/jimmunol.146.10.3365","article-title":"Cytokines in chronic inflammatory arthritis. IV. Analysis of the synovial cells involved in granulocyte macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-\u03b1","volume":"146","author":"Alvaro-Gracia","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/stem.5530090201","article-title":"The leukemia inhibitory factor (LIF)","volume":"9","author":"Metcalf","year":"1991","journal-title":"Int. J. Cell Cloning"},{"key":"10.1006\/clin.1996.4296_II964296C130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI115964","article-title":"Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis","volume":"90","author":"Lotz","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C131","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI116363","article-title":"Induction of cytokine expression by leukemia inhibitory factor","volume":"91","author":"Villiger","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C132","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780360707","article-title":"Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides","volume":"36","author":"Waring","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C133","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/art.1780360608","article-title":"Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor \u03b1","volume":"36","author":"Campbell","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C134","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/endo-126-3-1416","article-title":"Leukemia inhibitory factor: A novel bone-active cytokine","volume":"126","author":"Reid","year":"1990","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C135","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/endo.132.3.8440191","article-title":"The effect of leukemia inhibitory factor on bone in vivo","volume":"132","author":"Cornish","year":"1993","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/endo-127-1-185","article-title":"Leukemia inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger ribonucleic acid level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells","volume":"127","author":"Noda","year":"1990","journal-title":"Endocrinology"},{"key":"10.1006\/clin.1996.4296_II964296C137","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4049\/jimmunol.150.4.1496","article-title":"Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-\u03b1","volume":"150","author":"Hamilton","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jcp.1041520110","article-title":"Leukemia inhibitory factor\/differentiation\u2013stimulation factor (LIF\/D-Factor): Regulation of its production and possible roles in bone metabolism","volume":"152","author":"Ishimi","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"10.1006\/clin.1996.4296_II964296C139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0049-0172(91)90018-U","article-title":"Oxygen radicals, inflammation, and arthritis: Pathophysiological consideration and implications for treatment","volume":"20","author":"Greenwald","year":"1911","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C140","first-page":"598","article-title":"Free radicals, antioxidants, and human disease: Where are we now?","volume":"119","author":"Halliwell","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1006\/clin.1996.4296_II964296C141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF01535259","article-title":"Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation","volume":"18","author":"Shingu","year":"1994","journal-title":"Inflammation"},{"key":"10.1006\/clin.1996.4296_II964296C142","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.50.3.147","article-title":"Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: Priming and activation in vivo","volume":"50","author":"Newcombe","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C143","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.4049\/jimmunol.140.7.2334","article-title":"The superoxide generation system of B cell lines","volume":"140","author":"Maly","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C144","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1073\/pnas.85.11.4046","article-title":"Measurement of endothelial cell free radical generation. Evidence for a central mechanism of free radical injury in postischemic tissue","volume":"85","author":"Zweier","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(89)91305-6","article-title":"Hypoxic-reperfusion injury in the inflamed human joint","volume":"i","author":"Blake","year":"1989","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4296_II964296C146","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.4049\/jimmunol.136.11.4220","article-title":"Stimulation of neutrophils by tumor necrosis factor","volume":"136","author":"Klebanoff","year":"1986","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C147","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0006-291X(86)90337-2","article-title":"Tumor necrosis factor provokes superoxide anion generation from neutrophils","volume":"137","author":"Tsujimoto","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C148","unstructured":"M. L. Tiku, J. B. Leisch, F. M. Robertson, 1988, Chondrocytes produce oxygen radicals after treatment with ConA, gamma interferon or tumor necrosis factor, Proceedings of the 52nd Annual Meeting of the American Rheumatism Association, American Rheumatism Association, Houston, TX"},{"key":"10.1006\/clin.1996.4296_II964296C149","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/BF01116694","article-title":"Oxygen-centered free radicals can efficiently degrade the polypeptide of proteoglycans in whole cartilage","volume":"4","author":"Dean","year":"1984","journal-title":"Biosci. Rep."},{"key":"10.1006\/clin.1996.4296_II964296C150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0098-2997(85)90001-9","article-title":"The importance of free radicals and catalytic metal ions in human diseases","volume":"8","author":"Halliwell","year":"1985","journal-title":"Mol. Aspects Med."},{"key":"10.1006\/clin.1996.4296_II964296C151","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-4165(85)90082-0","article-title":"Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage","volume":"838","author":"Bates","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/clin.1996.4296_II964296C152","article-title":"Degradation of cartilage proteoglycans and collagen by superoxide radical","volume":"19","author":"Greenwald","year":"1976","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C153","first-page":"45","article-title":"Hydrogen peroxide-initiated animal model of acute inflammation","volume":"28","author":"Dabbagh","year":"1989","journal-title":"Br. J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10715768509056534","article-title":"Determination of dehydroascorbic acid and ascorbic acid in serum and synovial fluid of patients with rheumatoid arthritis","volume":"1","author":"Lunec","year":"1986","journal-title":"Free Radical Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/0006-291X(80)90113-8","article-title":"Isolation and properties of oxidised alpha-1-proteinase inhibitor from human rheumatoid synovial fluid","volume":"96","author":"Wong","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C156","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/cs0660691","article-title":"Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients","volume":"66","author":"Rowley","year":"1984","journal-title":"Clin. Sci."},{"key":"10.1006\/clin.1996.4296_II964296C157","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.53.1.51","article-title":"Serum antioxidants and risk of rheumatoid arthritis","volume":"53","author":"Heliovaara","year":"1994","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C158","first-page":"465","article-title":"Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis","volume":"7","author":"Honkanen","year":"1989","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C159","first-page":"1628","article-title":"Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis","volume":"15","author":"Imadaya","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10715768609088054","article-title":"Anti-inflammatory activity of superoxide dismutases: Comparison of enzymes from different sources in different models in rats: Mechanism of action","volume":"2","author":"Michelson","year":"1986","journal-title":"Free Radical Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C161","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/ard.51.11.1261","article-title":"Drug derived radicals: Mediators of the side effects of anti inflammatory drugs?","volume":"51","author":"Halliwell","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C162","first-page":"230","article-title":"Increased nitric oxide levels in patients with rheumatoid arthritis","volume":"23","author":"Ueki","year":"1996","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C163","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.1780360803","article-title":"Nitric oxide and arthritis","volume":"36","author":"Stefanovic-Racic","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C164","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatoid diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C165","first-page":"R9","article-title":"Elevated nitrates in inflammatory joint disease: Nitric oxide in arthritis","volume":"35","author":"Jacob","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C166","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/0006-291X(90)91583-E","article-title":"Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages","volume":"172","author":"DiRosa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/clin.1996.4296_II964296C167","series-title":"The Biology of Nitric Oxide","article-title":"Possible scavenger effect of salicylic acid on nitric oxide production in vitro","author":"Carrallo","year":"1992"},{"key":"10.1006\/clin.1996.4296_II964296C168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.1780350106","article-title":"Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury","volume":"35","author":"Walakovits","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C169","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02259605","article-title":"Dithiocarbamates inhibit IL-1-induced cartilage degradation in bovine articular cartilage explants","volume":"45","author":"Oleksyszyn","year":"1996","journal-title":"Inflam. Res."},{"key":"10.1006\/clin.1996.4296_II964296C170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.1780360313","article-title":"The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase\u2013TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis","volume":"36","author":"Clark","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C171","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/art.1780380803","article-title":"Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation","volume":"38","author":"Manicourt","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C172","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.1780370802","article-title":"Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?","volume":"37","author":"Vincenti","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C173","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2249.1993.tb05992.x","article-title":"The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells","volume":"94","author":"Shingu","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C174","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1988.tb00741.x","article-title":"Regulation of IgG1 and IgE production by interleukin-4","volume":"102","author":"Snapper","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1006\/clin.1996.4296_II964296C175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1988.tb00744.x","article-title":"Molecular biology of interleukin-4 and interleukin-5 genes and biology of their products that stimulate B cells, T cells and hematopoietic cells","volume":"102","author":"Yokota","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1006\/clin.1996.4296_II964296C176","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4049\/jimmunol.140.2.456","article-title":"Expression of high affinity receptors for murine interleukine-4 (BSF-1) on hemopoietic and nonhemopoietic cells","volume":"140","author":"Lowenthal","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C177","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V76.7.1392.1392","article-title":"Interleukin-4 (IL-4) inhibits secretion of IL-1b, tumor necrosis factor \u03b1, and IL-6 by human monocytes","volume":"76","author":"TeVelde","year":"1990","journal-title":"Blood"},{"key":"10.1006\/clin.1996.4296_II964296C178","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","article-title":"Potential anti-inflammatory effects of interleukin-4: Suppression of human monocyte tumor necrosis factor \u03b1, interleukin-1, and prostaglandin E2","volume":"86","author":"Hart","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C179","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jlb.56.4.507","article-title":"Interleukin-4 suppresses inflammatory cytokine gene transcription in porcine macrophages","volume":"56","author":"Zhou","year":"1994","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clin.1996.4296_II964296C180","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/art.1780350805","article-title":"Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis","volume":"35","author":"Miossec","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C181","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/art.1780371202","article-title":"Interleukin-4 inhibits bone resorption through an effect on osteoclasts and pro-inflammatory cytokines in an exvivo model of bone resorption in rheumatoid arthritis","volume":"37","author":"Miossec","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1996.4296_II964296C182","first-page":"1740","article-title":"Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants","volume":"22","author":"Yeh","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C183","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.54.10.836","article-title":"Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-I activation is inhibited by interleukin-4","volume":"54","author":"Van Room","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/clin.1996.4296_II964296C184","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.8332913","article-title":"Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4","volume":"261","author":"Colotta","year":"1993","journal-title":"Science"},{"key":"10.1006\/clin.1996.4296_II964296C185","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.4049\/jimmunol.134.6.3868","article-title":"Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor","volume":"134","author":"Arend","year":"1985","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C186","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4049\/jimmunol.139.5.1546","article-title":"A urine inhibitor of interleukin-1 activity that blocks ligand bindings","volume":"139","author":"Seckinger","year":"1987","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C187","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1073\/pnas.89.9.4076","article-title":"Coordinated anti inflammatory effects of interleukin-4: Interleukin-4 suppresses interleukin-1 production by up-regulating gene expression and synthesis of interleukin-1 receptor antagonist","volume":"89","author":"Vannier","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1996.4296_II964296C188","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood"},{"key":"10.1006\/clin.1996.4296_II964296C189","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V77.9.1859.1859","article-title":"Interleukin-4: A prototypic immunoregulatory lymphokine","volume":"77","author":"Paul","year":"1991","journal-title":"Blood"},{"key":"10.1006\/clin.1996.4296_II964296C190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1172\/JCI113891","article-title":"Function and heterogeneity of human Fc receptors for immunoglobulin G","volume":"83","author":"Unkeless","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C191","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","article-title":"Identification and characterization of a novel monocyte subpopulation in human peripheral blood","volume":"74","author":"Passlick","year":"1989","journal-title":"Blood"},{"key":"10.1006\/clin.1996.4296_II964296C192","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1084\/jem.167.2.408","article-title":"CD16: Developmentally regulated IgG Fc receptors on cultured monocytes","volume":"167","author":"Clarkson","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4296_II964296C193","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.144.9.3444","article-title":"Selective induction of Fc RIII on human monocytes by transforming growth factor-\u03b2","volume":"144","author":"Welch","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C194","first-page":"A1755","article-title":"Regulation of Fc RIII expression on inflammatory synovial monocytes by transforming growth factor beta","volume":"4","author":"Welch","year":"1990","journal-title":"FASEB J."},{"key":"10.1006\/clin.1996.4296_II964296C195","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.4049\/jimmunol.147.6.1843","article-title":"IL-4 antagonizes induction of Fc RIII (CD16) expression by transforming growth factor-\u03b2 on human monocytes","volume":"147","author":"Wong","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C196","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2141.1994.tb04817.x","article-title":"Recombinant human interleukin-4 inhibits the production of granulocyte\u2013macrophage colony stimulating factor by blood mononuclear cells","volume":"86","author":"Sato","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1006\/clin.1996.4296_II964296C197","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1002\/eji.1830241247","article-title":"Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes","volume":"24","author":"Dechant","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C198","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.4049\/jimmunol.143.9.3020","article-title":"IL-4 inhibits H22","volume":"143","author":"Lehn","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C199","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4049\/jimmunol.144.2.625","article-title":"IL-4 inhibits superoxide production by human mononuclear phagocytes","volume":"144","author":"Abramson","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C200","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/eji.1830241013","article-title":"Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon","volume":"24","author":"Sands","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C201","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/eji.1830220911","article-title":"Immunosuppression induced by nitric oxide and its inhibition by interleukin-4","volume":"22","author":"Al-Ramadi","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C202","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1172\/JCI115872","article-title":"Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4","volume":"90","author":"Lacraz","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1996.4296_II964296C203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0021-9258(18)48525-0","article-title":"Interleukin 4 inhibition of prostaglandin E2","volume":"267","author":"Corcoran","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1996.4296_II964296C204","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/excr.1996.0126","article-title":"Inhibition by interleukin-4 of stromelysin expression in human skin fibroblasts: Role of PKC","volume":"224","author":"Prontera","year":"1996","journal-title":"Exp. Cell. Res."},{"key":"10.1006\/clin.1996.4296_II964296C205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/rheumatology\/34.2.101","article-title":"The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation","volume":"34","author":"Shingu","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"10.1006\/clin.1996.4296_II964296C206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1H2","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C207","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00002371-199402000-00009","article-title":"Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanoma","volume":"15","author":"Margolin","year":"1994","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"key":"10.1006\/clin.1996.4296_II964296C209","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0091-6749(92)90101-7","article-title":"The effect of IL-4 on human nasal nucosal responses","volume":"90","author":"Emery","year":"1992","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122996942968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122996942968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:11:01Z","timestamp":1758762661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122996942968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":209,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["S0090122996942968"],"URL":"https:\/\/doi.org\/10.1006\/clin.1996.4296","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1997,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights into the Pathogenesis and Treatment of Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1996.4296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}